Plasminogen activators: A comparison

Vascular Pharmacology

Volumn 44, Issue 1, 2006, Pages 1-9

  Baruah, Dev B ^a   Dash, Rajendra N ^a   Chaudhari, M R ^a   Kadam, S S ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Acute myocardial infarction; Alteplase; Bat PA; Lanoteplase; Plasminogen activator; Prourokinase; Pulmonary embolism; Reteplase; Staphylokinase; Streptokinase; Tenecteplase; Urokinase

Indexed keywords

ALTEPLASE; ANISTREPLASE; DESMOTEPLASE; FIBRINOLYTIC AGENT; LANOTEPLASE; MONTEPLASE; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PROUROKINASE; RETEPLASE; STAPHYLOKINASE; STREPTOKINASE; TENECTEPLASE; UROKINASE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANAPHYLAXIS; BLEEDING; BOLUS INJECTION; CLINICAL TRIAL; DEATH; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FIBRINOGENOLYSIS; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; IMMUNE RESPONSE; INCIDENCE; LUNG EMBOLISM; MORTALITY; PERIPHERAL VASCULAR DISEASE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THROMBOSIS; VASCULAR PATENCY;

ANISTREPLASE; CARDIOVASCULAR DISEASES; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; FIBRINOLYTIC AGENTS; HUMANS; METALLOENDOPEPTIDASES; PLASMINOGEN ACTIVATORS; PRACTICE GUIDELINES; STREPTOKINASE;

EID: 29144447912     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.09.003     Document Type: Review

References (42)

1. Anirban Banerjee, Yusuf Chisti, and U.C. Banerjee Streptokinase - a clinically useful thrombolytic agent research review paper Biotechnol. Adv. 22 2004 287 307
2. M. Belkin, B. Belkin, C.A. Bucknam, J.J. Straub, and R. Lowe Intra arterial fibrinolytic therapy, efficacy of streptokinase vs urokinase Arch. Surg. 121 7 1986 769 773 (Jul)
3. Caridi, J.G., et al., 2005. Thrombolysis. www.venousaccess.com/ thrombolysis.htm, Dated 12.03.2005.
4. Francis J. Castellino, and James M. Sodetz Methods in Enzymology vol. 45 1977 244 257
5. CIMS India Current Index of Medical Specialities-88, India, January 2005 2005 156 159
6. Robert W. Colman Jack Hirsh Victor J. Marder Edwin W. Salzman Hemostasis and Thrombosis, Basic Principle and Clinical Practices 3rd edition 1994 J.B. Lipincott Company Philadelphia
7. Cramer, P., Martinet, J., 2005. Thrombolytic agents. www.Bioimpact.org Sep. 2004. www.france-biotech.org/Load.asp? ID DOC=1297.
8. Dectcher, Steven R., Jaff, Michal R. Pharmacologic and clinical characteristics of thrombolytic agents. [Rev Cardiovasc Med. 2002; 3 (suppl 2): S25-S33] (www.medreviews.com/pdf/articles/RICM3Suppl2S25pdf ).
9. Feied, C., Handler, J.A., 2004. Thrombolytic therapy. www.emedicine.com/emerg/topic831.htm, Dated 12.03.2005.
10. Goodman, Louis S., Gillman, Alfred, 1995. The Pharmacological Basis of Therapeutics, 5th edition. Page 956,1364,1365. Macmillan publishing Co. Inc. New York.
11. P.D. Heijer Lanoteplase beats alteplase in AMI J. Watch Cardiol. 1998 (December 18)
12. Mark D. Hiatt Thrombolytic therapy with streptokinase and tissue plasminogen activation in a patient with suspected AMI. A decision analysis Cardiology 91 1999 243 249
13. http://www.cardiologyrounds.ca/crus/crcane-06-98.pdf. "New directions in thrombolytic therapy" Wayne hoping Kong, Shaun Goodman.
14. http://www.medscape.com/viewarticle. "Pharmacology of New Plasminogen Activators".
15. Omer Iqbal, and Mahmut Tobu The role of thrombolytic drugs in the management of AMI and Stroke Turk. J. Haematol. 19 2 2002 151 177 (www.tjh.com.tr/pdf,php3?id=192 )
16. H.s. Lee How safe is re administration of steptokinase Drug Safety 2 1995 76 80 (Aug. 13)
17. Lievadot, Joan P., Giugliano, Robert P. "New thrombolytic agents: does direct angioplasty still have a role?" current interventional cardiology reports 2000, 2: 250-257. www.biomedcentral.com.
18. National academy of science of the United States, Jan 19, 1999, V96 i2 p 686.
19. G. Nguyen, and M. Samama New thromobolytic agent (Article in French) Ann. Biol. Clin. (Paris) 45 2 1987 212 218
20. Thomas K. Nordt, and Martin Moser Pharmacokinetics and pharmacodynamics of lanoteplase Thromb. Haemost. 82 1999 121 123
21. Ouriel, K., 2002. Safety and efficacy of various thrombolytic agent, vol. 3 suppl. 2, reviews in cardiovascular medicine s17, http://www.medreviews.com/ pdfs/articles/RICM_3suppl2_s17.pdf, Dated 15.03.2005.
22. K. Ouriel, E.L. Welch, and C.K. Shortell Comparison of streptokinase, urokinase and recombinant tissue plasminogen activator in an in vitro model of venous thrombosis J. Vasc. Surg. 22 5 1995 593 597 (Nov.)
23. Ouriel, Kenneth, Gray, Bruce, Clair, Daniel G., Olin, Jeffrey, 2000. "Complication associated with the use of urokinase and recombinant. Tissue plasminogen activator for catheter directed peripheral arterial and venous thrombolysis", www.medreviews.com.
24. Productmonograph PRCathflo® (alteplase, recombinant), www.rochecanada.com/pdf/Cathflo%20PM%20E.pdf., Dated 22.03.2005.
25. RecombinantHumanTissuePlasminogenActivator-TPA, www.prospec.co.il/ ∼prospec/cart/catalog/rHuTPA.html, ProSpec-Tany TechnoGene Ltd, Dated 11.03.2005.
26. Jay P. Rho, and Stan G. Louie Hand Book of Pharmaceutical Biotechnology, Chapter-4 2004 65 78
27. A.M. Ross New plasminogen activators-a clinical review Clin. Cardiol. 22 1999 165 171 http://www.clinicalcardiology.org/briefs/9903briefs/22-165.html
28. Satoshkar, R.S., Bhandarkar, S.D., Ainapure, S.S., 1998 "Pharmacology and Therapeutics". Revised 16th edition. Pages 460, 461, 1030, 1031. Popular prakashan, Mumbai, India.
29. STN easy online database. Topic - "plasminogen and plasminogen activator" www.stneasy.cas.org.
30. Tenecteplase - clinical pharmacology, www.rxlist.com/generic2/ tenecteplase_cp-htm, Dated 20.04.2005.
31. J.E. Topal A comparison of Reteplase with Alteplase for AMI The New England Journal of Medicine 337 1997 1118 1123
32. K.D. Tripathi Essentials of Medical Pharmacology 4th edition 2003 Jaypee brothers New Delhi-110002 609 611
33. A. Van Breda, B.T. Katzen, and A.S. Beutsch Urokinase VS streptokinase in local thrombolysis Radiology 165 1 1987 109 111 (Oct)
34. Vander Schueren Recombinant staphylokinase Circulation 92 1995 2044 2057 www.fpnotebook.com Dated 14.03.2005
35. S. Vander Schueren, and L. Barrios A randomized trial of r-staphylokinase vs alteplase for coronary artery patency in AMI, the STAR trial group Circulation 92 8 1995 20449 (Oct. 15)
36. www.biology.iupui.edu/biocourses/N100/2KS.
37. www.Biopharma.com. (Biopharmaceutical product in the US market).
38. www.gene.com.
39. www.gpnotebook.co.uk (Tissue plasminogen activator).
40. www.Healthtouch.com (Alteplase, recombinant (Injection)).
41. www.madsci.com/Manu/ches_thr.htm (Thrombolytics).
42. www.pharmacy.pitt.edu/pdf/cathflomonographfinalpdf (Cathflo Activase®(t-PA, alteplase)).